Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7236)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2019 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Affonso BB, Galastri FL, da Motta Leal Filho JM, Nasser F, Falsarella PM, Cavalcante RN, de Almeida MD, Felga GEG, Valle LGM, Wolosker N. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging. World J Gastroenterol 2019; 25(37): 5687-5701 [PMID: 31602168 DOI: 10.3748/wjg.v25.i37.5687] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i37/5687.htm |
| Number | Citing Articles |
| 1 |
Cyrill Wehling, Michael T. Dill, Alexander Olkus, Christoph Springfeld, De-Hua Chang, Patrick Naumann, Thomas Longerich, Clemens Kratochwil, Arianeb Mehrabi, Uta Merle, Jan Pfeiffenberger, Christian Rupp, Karl Heinz Weiss, Markus Mieth. Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities. Journal of Cancer Research and Clinical Oncology 2021; 147(8): 2471 doi: 10.1007/s00432-021-03528-3
|
| 2 |
Rubén Caiña Ruiz, Enrique Toledo Martínez, Edward Joseph Anderson, Víctor Valbuena Jabares, Roberto Fernández Santiago, Federico Castillo, Juan Echeverri, Mar Achalandabaso, Francisco José González Sánchez, Emilio Fábrega, Antonio Cuadrado, José Ignacio Fortea, Javier Crespo, Juan Carlos Rodríguez Sanjuán. Effect of Bridging Therapy on Survival in Hepatocellular Carcinoma Patients Who Receive Liver Transplants. Transplantation Proceedings 2022; 54(9): 2528 doi: 10.1016/j.transproceed.2022.09.007
|
| 3 |
Kelley G. Núñez, Tyler Sandow, Daniel Fort, Mina Hibino, Paige Wright, Ari J. Cohen, Paul T. Thevenot. PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival. Cancer Immunology, Immunotherapy 2022; 71(6): 1453 doi: 10.1007/s00262-021-03087-z
|
| 4 |
Kohei Ogawa, Yasutsugu Takada. Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation. Cancers 2022; 14(2): 396 doi: 10.3390/cancers14020396
|
| 5 |
Allison B. Couillard, Emily A. Knott, Annie M. Zlevor, Joshua D. Mezrich, Mircea M. Cristescu, Parul Agarwal, Timothy J. Ziemlewicz, Colin Longhurst, Meghan G. Lubner, J. Louis Hinshaw, Adnan Said, Paul F. Laeseke, Michael R. Lucey, John P. Rice, David Foley, David Al-Adra, Fred T. Lee. Microwave Ablation as Bridging to Liver Transplant for Patients with Hepatocellular Carcinoma: A Single-Center Retrospective Analysis. Journal of Vascular and Interventional Radiology 2022; 33(9): 1045 doi: 10.1016/j.jvir.2022.05.019
|
| 6 |
Eleonora De Martin, Thomas Berg, Marina Berenguer, Patrizia Burra, Constantino Fondevila, Julie K. Heimbach, Georges-Philippe Pageaux, Alberto Sanchez-Fueyo, Christian Toso. EASL Clinical Practice Guidelines on liver transplantation. Journal of Hepatology 2024; 81(6): 1040 doi: 10.1016/j.jhep.2024.07.032
|
| 7 |
Chao Jiang, Xiao-Dong Sun, Wei Qiu, Yu-Guo Chen, Da-Wei Sun, Guo-Yue Lv. Conversion therapy in liver transplantation for hepatocellular carcinoma: What's new in the era of molecular and immune therapy?. Hepatobiliary & Pancreatic Diseases International 2023; 22(1): 7 doi: 10.1016/j.hbpd.2022.10.006
|
| 8 |
Ana-Maria Bucalau, Illario Tancredi, Gontran Verset. In the Era of Systemic Therapy for Hepatocellular Carcinoma Is Transarterial Chemoembolization Still a Card to Play?. Cancers 2021; 13(20): 5129 doi: 10.3390/cancers13205129
|
| 9 |
Deniz Can Guven, Hasan Cagri Yildirim, Elvin Chalabiyev, Fatih Kus, Feride Yilmaz, Serkan Yasar, Arif Akyildiz, Burak Yasin Aktas, Suayib Yalcin, Omer Dizdar. Emerging treatment strategies in hepatobiliary cancer. Expert Review of Anticancer Therapy 2023; 23(3): 243 doi: 10.1080/14737140.2023.2183844
|
| 10 |
Roberto Minici, Maria Anna Siciliano, Michele Ammendola, Rita Carlotta Santoro, Vito Barbieri, Girolamo Ranieri, Domenico Laganà. Prognostic Role of Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR), Platelet-to-Lymphocyte Ratio (PLR) and Lymphocyte-to-C Reactive Protein Ratio (LCR) in Patients with Hepatocellular Carcinoma (HCC) undergoing Chemoembolizations (TACE) of the Liver: The Unexplored Corner Linking Tumor Microenvironment, Biomarkers and Interventional Radiology. Cancers 2022; 15(1): 257 doi: 10.3390/cancers15010257
|
| 11 |
Beatriz G. de Morais, Alex F. Horbe, Gabriela Perdomo Coral, Raquel de F. Jotz, Priscila C. Fontana, Angelo A. Mattos. Results of hepatocellular carcinoma downstaging through hepatic transarterial chemoembolization in liver transplantation. European Journal of Gastroenterology & Hepatology 2025; 37(1): 77 doi: 10.1097/MEG.0000000000002869
|
| 12 |
Leonardo Guedes Moreira Valle, Marcela Juliano Silva Cunha, Bruno Pagnin Schmid, Priscila Mina Falsarella, Marcelo Bruno de Rezende, Guilherme Eduardo Gonçalves Felga, Renata Emy Ogawa, Rodrigo Gobbo Garcia, Breno Boueri Affonso, Felipe Nasser, Francisco Leonardo Galastri. Radiological characteristics of hepatocellular carcinoma that achieved complete response after chemoembolization with drug-eluting beads for liver transplantation planning. einstein (São Paulo) 2023; 21 doi: 10.31744/einstein_journal/2023AO0307
|
| 13 |
Hugues Radovitch, Sarah Le Sagere, Bastien Cabarrou, Charlotte Maulat, Paul Boulard, Nadim Farès, Charline Zadro, Jean-Marie Peron, Bertrand Suc, Fatima-Zohra Mokrane, Fabrice Muscari. Influence of the Radiological Response on Histological Necrosis and on the Survival of Patients Treated With Transarterial Chemoembolization for Hepatocellular Carcinoma Secondary to Cirrhosis on the Liver Transplantation Waiting List. Transplantation Proceedings 2024; 56(8): 1774 doi: 10.1016/j.transproceed.2024.08.033
|
| 14 |
Abu Bakar Hafeez Bhatti, Muhammad Hassan, Atif Rana, Nusrat Yar Khan, Zahid Amin Khan, Haseeb Haider Zia. Risk Score Model for Liver Transplant Outcomes after Preoperative Locoregional Therapy for Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2022; 53(1): 84 doi: 10.1007/s12029-020-00554-1
|
| 15 |
Joseph W. Franses, Andrew X. Zhu. Neoadjuvant Approaches in Hepatocellular Carcinoma: There's No Time Like the Present. Clinical Cancer Research 2022; 28(13): 2738 doi: 10.1158/1078-0432.CCR-22-0025
|
| 16 |
Joaquim Maurício da Motta-Leal-Filho. Locoregional therapies for the treatment of locally advanced hepatocellular carcinoma. Radiologia Brasileira 2021; 54(3): IX doi: 10.1590/0100-3984.2021.54.3e3
|
| 17 |
Thiago José Penachim. A valuable tool for the treatment of hepatocellular carcinoma. Radiologia Brasileira 2023; 56(5): VII doi: 10.1590/0100-3984.2023.56.5e2
|
| 18 |
Roberto Iezzi, Alessandro Posa, Andrea Contegiacomo, In Joon Lee, Reto Bale, Alessandro Tanzilli, Lorenzo Tenore, Felice Giuliante, Antonio Gasbarrini, Shraga Nahum Goldberg, Tobias Jakobs, Maurizio Pompili, Irene Bargellini, Evis Sala, Hyo-Cheol Kim. Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives. Cancers 2023; 15(15): 3988 doi: 10.3390/cancers15153988
|
| 19 |
Yanxu Li, Weiben Ji, Chaoying Wang, Lai Chang, Quan Zhang, Jiefeng Gao, Tao Wang, Wei Wu. Poly l-Lactic Acid Nanofiber Membrane Effectively Inhibits Liver Cancer Cells Growth and Prevents Postoperative Residual Cancer Recurrence. ACS Applied Materials & Interfaces 2024; doi: 10.1021/acsami.4c18625
|
| 20 |
Liang Cai, Honglu Li, Jiang Guo, Wenpeng Zhao, Youjia Duan, Xiaopu Hou, Long Cheng, Hongliu Du, Xihong Shao, Zhenying Diao, Changqing Li. Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort study. Clinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101535 doi: 10.1016/j.clinre.2020.09.002
|
| 21 |
Ornella Moschovaki-Zeiger, Nikolaos-Achilleas Arkoudis, Athanasios Giannakis, Stavros Grigoriadis, Fotis Anagnostopoulos, Stavros Spiliopoulos. Biodegradable Microspheres for Transarterial Chemoembolization in Malignant Liver Disease. Medicina 2024; 60(4): 678 doi: 10.3390/medicina60040678
|
| 22 |
Brett Marinelli, Mario Cedillo, Sara D. Pasik, Dudley Charles, Shashi Murthy, Rahul S. Patel, Aaron Fischman, Monda Ranade, Vivian Bishay, Scott Nowakowski, Max Sung, Thomas Marron, Robert Lookstein, Myron Schwartz, Edward Kim. Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients. Journal of Vascular and Interventional Radiology 2020; 31(11): 1729 doi: 10.1016/j.jvir.2020.07.009
|
| 23 |
Giammauro Berardi, Nicola Guglielmo, Alessandro Cucchetti, Sofia Usai, Marco Colasanti, Roberto Luca Meniconi, Stefano Ferretti, Germano Mariano, Marco Angrisani, Rosa Sciuto, Federica Di Stefano, Guido Ventroni, Pascale Riu, Valerio Giannelli, Adriano Pellicelli, Raffaella Lionetti, Giampiero D’Offizi, Giovanni Vennarecci, Micaela Maritti, Luigi Tritapepe, Roberto Cianni, Giuseppe Maria Ettorre. Transarterial Radioembolization Can Downstage Intermediate and Advanced Hepatocellular Carcinoma to Liver Transplantation. Transplantation 2025; 109(1): e54 doi: 10.1097/TP.0000000000005204
|
| 24 |
Guangjiang Jiang, Sunbin Ling, Qifan Zhan, Li Zhuang, Xiao Xu. Downstaging treatment for patients with hepatocelluar carcinoma before transplantation. Transplantation Reviews 2021; 35(2): 100606 doi: 10.1016/j.trre.2021.100606
|
| 25 |
Haoran Huo, Xiaoying Wang, Shan Xu, Xiaotong Niu, Limin Cheng, Zengjiang Yuan, Shuang Huo, Pingping Fang. Transarterial chemoembolization plus camrelizumab is an effective and tolerable bridging therapy for patients with intermediate‑stage hepatocellular carcinoma: A pilot study. Oncology Letters 2023; 26(5) doi: 10.3892/ol.2023.14052
|
| 26 |
Peng Guo, Junjun Zheng, Xingtao Pi, Feng Gao, Yushan Zhao, Chunming Xie, Wendong Cao. Transarterial chemoembolization combined with radiofrequency ablation for medium and large hepatocellular carcinoma: insufficient ablation is associated with intrahepatic distant metastasis and extrahepatic metastasis. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1283843
|
| 27 |
Marcello Di Martino, Alessandro Vitale, Daniele Ferraro, Marilisa Maniscalco, Donatella Pisaniello, Giuseppe Arenga, Federica Falaschi, Alfonso Terrone, Alessandro Iacomino, Alfonso Galeota Lanza, Ciro Esposito, Umberto Cillo, Giovanni Vennarecci. Downstaging Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation: A Systematic Review and Meta-Analysis on Intention-to-Treat Outcomes. Cancers 2022; 14(20): 5102 doi: 10.3390/cancers14205102
|
| 28 |
宁宁 胡. Effect of Preoperative Treatment on Survival of Patients with Hepatocellular Carcinoma after Liver Transplantation. Advances in Clinical Medicine 2023; 13(03): 2903 doi: 10.12677/ACM.2023.133411
|
| 29 |
Haytham Derbel, Athena Galletto Pregliasco, Sébastien Mulé, Julien Calderaro, Youssef Zaarour, Laetitia Saccenti, Mario Ghosn, Edouard Reizine, Maxime Blain, Alexis Laurent, Raffaele Brustia, Vincent Leroy, Giuliana Amaddeo, Alain Luciani, Vania Tacher, Hicham Kobeiter. Should Hypervascular Incidentalomas Detected on Per-Interventional Cone Beam Computed Tomography during Intra-Arterial Therapies for Hepatocellular Carcinoma Impact the Treatment Plan in Patients Waiting for Liver Transplantation?. Cancers 2024; 16(13): 2333 doi: 10.3390/cancers16132333
|
| 30 |
Giacomo Zanus, Giovanni Tagliente, Serena Rossi, Alessandro Bonis, Mattia Zambon, Michele Scopelliti, Marco Brizzolari, Ugo Grossi, Maurizio Romano, Michele Finotti. Pulsed Microwave Liver Ablation: An Additional Tool to Treat Hepatocellular Carcinoma. Cancers 2022; 14(3): 748 doi: 10.3390/cancers14030748
|
| 31 |
Zongyi Yin, Dongying Chen, Shuang Liang, Xiaowu Li. Neoadjuvant Therapy for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 929 doi: 10.2147/JHC.S357313
|
| 32 |
Silvia Cesario, Virginia Genovesi, Francesca Salani, Enrico Vasile, Lorenzo Fornaro, Caterina Vivaldi, Gianluca Masi. Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution. Life 2023; 13(7): 1562 doi: 10.3390/life13071562
|
| 33 |
Xinyu Bi, Haitao Zhao, Hong Zhao, Guangming Li, Xiaodong Wang, Bo Chen, Wen Zhang, Xu Che, Zhen Huang, Yue Han, Liming Jiang, Yongkun Sun, Zhengqiang Yang, Jianguo Zhou, Yefan Zhang, Zhenyu Zhu, Minshan Chen, Shuqun Cheng, Jianqiang Cai. Consensus of Chinese Experts on Neoadjuvant and Conversion Therapies for Hepatocellular Carcinoma: 2023 Update. Liver Cancer 2024; : 1 doi: 10.1159/000541249
|
| 34 |
Alfonso Jose Holguín Holguín, Juan Sebastián Toro Gutierrez, Luis Alfonso Bustamante-Cristancho, Tatiana Alvarez Saa, Juan C. Camacho. Bland Embolization and Transarterial Chemoembolization in Hepatocarcinoma. Digestive Disease Interventions 2024; 8(01): 52 doi: 10.1055/s-0043-1772742
|
| 35 |
Roberto Minici, Michele Ammendola, Francesco Manti, Maria Anna Siciliano, Marco Minici, Iman Komaei, Giuseppe Currò, Domenico Laganà. Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in the Downstaging of Intermediate-Stage Hepatocellular Carcinoma (HCC) in Patients With a Child-Pugh Score of 8-9. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.634087
|
| 36 |
Laura Crocetti, Elena Bozzi, Paola Scalise, Irene Bargellini, Giulia Lorenzoni, Davide Ghinolfi, Daniela Campani, Emanuele Balzano, Paolo De Simone, Roberto Cioni. Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation. Cancers 2021; 13(21): 5558 doi: 10.3390/cancers13215558
|
| 37 |
Basheer Elsolh, Zubair Bayat, Dennis Lyu, Jules Lin, Elliot Wakeam. Lung transplantation for lung cancer: A systematic review of the literature. The Journal of Heart and Lung Transplantation 2023; 42(10): 1425 doi: 10.1016/j.healun.2023.05.011
|
| 38 |
Takeshi Takamoto, Yuta Maruki, Shunsuke Kondo. Recent updates in the use of pharmacological therapies for downstaging in patients with hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 2023; 24(14): 1567 doi: 10.1080/14656566.2023.2229728
|
| 39 |
Qi Liu, Renjie Zhang, Weixi Shen. Advancements in locoregional therapy for advanced hepatocellular carcinoma: Emerging perspectives on combined treatment strategies. European Journal of Surgical Oncology 2025; 51(2): 109502 doi: 10.1016/j.ejso.2024.109502
|
| 40 |
R. E. Kalinin, E. P. Kulikov, N. I. Verkin, S. A. Mertsalov, E. Yu. Golovkin, I. N. Shanaev, O .V. Zotova. Intra-arterial chemoembolization as a component of neoadjuvant treatment of rectal cancer. Literature review. Сибирский научный медицинский журнал 2024; 44(5): 6 doi: 10.18699/SSMJ20240501
|
| 41 |
Yanxu Li, Hao Zou, Zekun Zheng, Zhuoheng Liu, Huiyuan Hu, Wei Wu, Tao Wang. Advances in the Study of Bioactive Nanoparticles for the Treatment of HCC and Its Postoperative Residual Cancer. International Journal of Nanomedicine 2023; : 2721 doi: 10.2147/IJN.S399146
|
| 42 |
Hui-Chuan Sun, Xiao-Dong Zhu. Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.772195
|